慢性阻塞性肺疾病早期筛查工具的研究现状
|
摘要
<正>慢性阻塞性肺疾病(简称慢阻肺)是指由于显著暴露于有毒颗粒或气体导致气道和(或)肺泡异常的一种常见、可预测、可治疗疾病,主要表现为持续呼吸系统症状和气流受限[1]。据报道,截止至2015年,我国慢阻肺患者数近1亿人,已经成为与高血压、糖尿病等量齐观的慢性疾病,构成重大疾病负担[2]。早在2011年,慢性阻塞性肺疾病全球创议(GOLD)曾指出慢阻肺是可预防、可治疗的疾病。
引文
[1]Global Strategy for the Diagnosis,Management,and Prevention o f COPD,Global Initiative for Chronic Obstructive Lung Disease(GOLD)2019[DB/OL].http://goldcopd.org/.
[2]Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):a national cross-sectional study[J].Lancet Respir Med,2018,391(10131):1706-1717.
[3]VestboJ,EdwardsLD,ScanlonPD,et al.Changes in forced expiratory volume in 1 second over time in COPD.[J].N Engl J Med,2011,365(13):1184-1192.
[4]Zhou Y,Zhong NS,Li X,et al.Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease[J].N Engl J Med,2017,377(10):923-935.
[5]Martinez FJ,Han MK,Allinson JP,et al.At the Root:Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease[J].Am J Respir Crit Care Med,2018,197(12):1540-1551.
[6]张荣葆,何权瀛,谭星宇.从高危人群中筛查诊断慢性阻塞性肺疾病的效果评估[J].中华结核和呼吸杂志,2009,32(1):17-20.
[7]孙士芳,邓在春,丁群力,等.肺功能检查早期筛查宁波地区慢性阻塞性肺疾病的临床应用[C]//浙江省医学会健康管理学分会学术年会暨健康管理学学科与学术发展论坛.2015.
[8]张晓雷,王辰.重视慢性阻塞性肺疾病的筛查与管理[J].中华健康管理学杂志,2015(4):250-253.
[9]Zaman M,Mahmood S,Altayeh A.Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation[J].Am J Med Sci,2010,339(5):411.
[10]?olak Y,Afzal S,Nordestgaard B G,et al.Young and middle-aged adults withairflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival:a population-based prospective cohort study.[J].Eur Respir J,2018.
[11]Dilektasli AG,Porszasz J,Casaburi R,et al.A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria[J].Chest,2016,150(5):1080-1090.
[12]Mirsadraee M,Boskabady MH,Attaran D.Diagnosis of chronic obstructive pulmonary disease earlier than current Global Initiative for Obstructive Lung Disease guidelines using a feasible spirometry parameter(maximal-mid expiratory flow/forced vital capacity).[J].Chron Respir Dis,2013,10(4):191-196.
[13]Vandevoorde J,Verbanck S,Schuermans D,et al.FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.[J].Chest,2005,127(5):1560-1564.
[14]Hankinson JL,Odencrantz JR,Fedan KB.Spirometric reference values froma sample of the general U.S.population.[J].Am J Respir Crit Care Med,1999,159(1):179-187.
[15]Kjeldgaard P,Lykkegaard J,Spillemose H,et al.Multicenter study of the COPD-6 screening device:feasible for early detection of chronic obstructive pulmonary disease in primary care?[J].Int J Chron Obstruct Pulmon Dis,2017,12:2323.
[16]Thorn J,Tilling B,Lisspers K,et al.Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care:a real-life study and cost-effectiveness analysis[J].Primy Care Respir J,2012,21(2):159.
[17]Bemt LVD,Wouters BCW,Grootens J,et al.Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care:a randomised cross-sectional study[J].NPJ Prim Care Respir Med.,2014,24:14033.
[18]Represas CR,Rial MB,Fernández VL,et al.Validación del dispositivo portátil COPD-6 para la detección de patologías obstructivas de la vía aérea[J].Arch Bronconeumol,2010,46(8):426-432.
[19]Miravitlles M,Llor C,Calvo E,et al.Validación de la versión traducida del Chronic Obstructive Pulmonary Disease-Population Screener,(COPD-PS).Su utilidad y la del FEV1/FEV6,para el diagnóstico de enfermedad pulmonar obstructiva crónica[J].Medicina Clinica,2012,139(12):522-530.
[20]Bateman ED,Hurd SS,Barnes PJ,et al.Global strategy for asthma management and prevention:GINA executive summary[J].Eur Respir J,2008,34(1):143-178.
[21]Chuaychoo B,Maranetra N,Naruman C,et al.The most cost-effective screening method for chronic obstructive pulmonary disease among the Bangkok elderly[J].J Med Assoc Thai,2003,86(12):1140-1148.
[22]Jackson H,Hubbard R.Detecting chronic obstructive pulmonary disease using peak flow rate:cross sectional survey[J].BMJ,2003,327(7416):653-654.
[23]Perez-Padilla R,Vollmer WM,Vázquez-García JC,et al.Can a normal peakexpiratory flow exclude severe chronic obstructive pulmonary disease?[J].Int J Tuberc Lung Dis,2009,13(3):387-393.
[24]田佳,冉丕鑫.成人PEF预计值公式建立及其在COPD患者中的气流受限初筛中作用研究[D].学位论文,广州医学院,2010
[25]刘亚男,许文兵,孟淑珍,等.探究峰流速仪呼气峰流速检测对慢性阻塞性肺疾病的筛查效力[J].中国呼吸与危重监护杂志,2015(3):250-254.
[26]Mahboub B,Alzaabi A,Soriano J B,et al.Case-finding of chronic obstructive pulmonar y disease with questionnaire,peak flow measurements and spirometry:a cross-sectional study[J].BMC Res Notes,2014,7(1):1-7.
[27]Jithoo A,Enright PL,Burney P,et al.Case-finding options for COPD:results from the Burden of Obstructive Lung Disease study[J].Eur Respir J,2013,41(3):548-555.
[28]冉丕鑫,王辰,姚婉贞,等.我国部分农村地区40岁以上女性慢性阻塞性肺疾病危险因素分析[J].中华内科杂志,2006,45(12):974-979.
[29]Pr iceDB,TinkelmanD G,Hal ber tR J,et al.Sy mptom-based questionnaire for identifying COPD in smokers.[J].Respiration,2006,73(3):285-295.
[30]Price DB,Tinkelman DG,Nordyke RJ,et al.Scoring System and Clinical Application of COPD Diagnostic Questionnaires[J].Chest,2006,129(6):1531-1539.
[31]Kawayama T,Minakata Y,Matsunaga K,et al.Validation of symptombased COPD questionnaires in Japanese subjects.[J].Respirology,2008,13(3):420-426.
[32]王娟,许文兵,曾学军,等.中文版慢性阻塞性肺疾病筛查问卷在吸烟者中的初步检验与评价[J].中华内科杂志,2012,51(4):311-312.
[33]石喆,王石林,汪海燕,等.适宜国人BMI分级的慢性阻塞性肺疾病筛查问卷的检验与评价[J].中华全科医师杂志,2014,13(3):184-187.
[34]Dag E,Bulcun E,Turkel Y,et al.Factors Influencing Cognitive Function in Subjects With COPD[J].Respir Care,2016,61(8):1044-1050.
[35]Hung WW,Wisnivesky JP,Siu AL,et al.Cognitive decline among patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2009,180(2):134-137.
[36]Torressánchez I,Rodríguezalzueta E,Cabreramartos I,et al.Cognitive impairment in COPD:a systematic review.[J].J Bras Pneumol,2015,41(2):182-190.
[37]Lópeztorres I,Valenza M C,Torressánchez I,et al.Changes in Cognitive Status in COPD Patients Across Clinical Stages[J].COPD,2015,13(3):327-332.
[38]Dalal AA,Demuromercon C,Lewis S,et al.Validation of alternate modes of administration of the lung function questionnaire(LFQ)in subjects with smoking history[J].Int J Chron Obstruct Pulmon Dis,2010,5:425-434.
[39]Hanania NA,Mannino DM,Yawn BP,et al.Predicting risk of airflow obstruction in primary care:Validation of the lung function questionnaire(LFQ)[J].Respir Med,2010,104(8):1160-1170.
[40]Morfeld M,Bullinger M,Nantke J,et al.[The version 2.0 of the SF-36Health Survey:results of a population-representative study].[J].Soz Praventivmed,2005,50(5):292-300.
[41]冉丕鑫,王辰,姚婉贞,等.体重指数与慢性阻塞性肺疾病及生活质量的关系[J].中华结核和呼吸杂志,2007,30(1):18-22.
[42]Harikkhan RI,Fleg JL,Wise RA.Body mass index and the risk of COPD[J].Chest,2002,121(2):370-376.
[43]Franssen FME,O’Donnell DE,Goossens GH,et al.Obesity and the lung:5·Obesity and COPD[J].Thorax,2008,63(12):1110-1117.
[44]Ora J,Laveneziana P,Ofir D,et al.Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance[J].Am J Respir Crit Care Med,2009,180(10):964-971.
[45]van den Bemt L,Smeele IJ,Kolkman M,et al.Low body mass index,airflow obstruction,and dyspnoea in a primary care COPD patient population[J].Prim Care Respir J,2010,19(2):118-123.
[46]Liu Y,Pleasants RA,Croft JB,et al.Body mass index,respiratory conditions,asthma,and chronic obstructive pulmonary disease[J].Respir Med,2015,109(7):851-859.
[47]Eisner MD,Blanc PD,Sidney S,et al.Body composition and functional limitation in COPD[J].Respir Res,2007,8(1):7.
[48]Steuten LMG,Creutzberg EC,Vrijhoef HJM,et al.COPD as a multicomponent disease:Inventory of dyspnoea,underweight,obesity and fat free mass depletion in primary care[J].Prim Care Respir J,2006,15(2):84-91.
[49]Zhou Y M,Chen SY,Tian J,et al.Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China[J].Int J Tuberc Lung Dis,2013,17(12):1645-51.
[50]Landis S H,Muellerova H,Mannino DM,et al.Continuing to Confront COPDInternational Patient Survey:methods,COPDprevalence,and disease burden in 2012-2013[J].Int J Chron Obstruct Pulmon Dis,2014,9:597-611.
[51]Foreman MG,Zhang L,Murphy J,et al.Early-onset chronic obstructive pulmonary disease is associated with female sex,maternal factors,and African American race in the COPDGene Study[J].Am J Respir Crit Care Med,2011,184(4):414-20.
[52]Varela MVL,Oca MMD,Halbert RJ,et al.Sex-related differences in COPD in five Latin American cities:the PLATINO study[J].Eur Respir J,2010,36(5):1034-1041.
[53]Wang H,Zhang S.Tumor classification based on orthogonal linear discriminant analysis[J].Biomed Mater Eng,2014,24(1):1399-405.
[54]Jun Hwa L,Kyung-Hee K,Ji-Won P,et al.Low-mass-ion discriminant equation:a new concept for colorectal cancer screening[J].Int JCancer,2014,134(8):1844.
[55]Cui J,Zhou Y,Tian J,et al.A discriminant function model as an alternative method to spirometry for COPD screening in primary care settings in China[J].J Thorac Dis,2012,4(6):594-600.
[56]Couillard A,Tremey E,Prefaut C,et al.The self-perception of dyspnoea threshold during the 6-min walk test:a good alternative to estimate the ventilatory threshold in chronic obstructive pulmonary disease[J].Int J Rehabil Res,2016,39(4):320-325.
[57]Chandra D,Wise RA,Kulkarni HS,et al.Optimizing the 6-min walk test as a measure of exercise capacity in COPD[J].Chest,2012,142(6):1545-1552.
[58]邵向荣.6 min步行试验对于慢性阻塞性肺疾病患者的早期筛查意义[J].实用临床医药杂志,2011,15(24):66-67.
[59]Holland AE,Spruit MA,Troosters T,et al.An official European Respiratory Society/American Thoracic Society technical standard:field walking tests in chronic respiratory disease[J].Eur Respir J,2014,44(6):1428-1446.
[60]张雯,孙兴国,彭立悦,等.不同表型的慢性阻塞性肺疾病患者运动能力的比较[J].中国实用内科杂志,2013,33(s1):51
[61]陈燕,熊英,李玲,等.慢性阻塞性肺疾病模型大鼠细胞因子水平变化的研究[J].中华疾病控制杂志,2015,19(8):839-842.
[62]凌燕君.COPD患者诱导痰Th17相关细胞因子与BODE指数和GOLD分级的相关性[J].中华全科医学,2017(5):802-804.
[63]高鹏.基于诱导痰炎症细胞分类的AECOPD新分型及其临床意义的研究[D].吉林大学,2013.
[64]李增艳,卜小宁,苗苗,等.稳定期慢性阻塞性肺疾病患者的去脂质量指数与骨强度的关系[J].中华结核和呼吸杂志,2015,38(1):50-54.
[65]袁俊亮,胡文立.慢性阻塞性肺疾病与认知功能障碍[J].国际呼吸杂志,2013,33(23):1814-1816.
[66]刘音,杨小东.机械通气慢性阻塞性肺病患者腹泻危险因素及致病菌分析[J].临床军医杂志,2018,46(8):928-931.
[67]Welte T,Vogelmeier C,Papi A.COPD:early diagnosis and treatment to slow disease progression.[J].Int J Clin Pract,2015,69(5):513-514.
[2]Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH]study):a national cross-sectional study[J].Lancet Respir Med,2018,391(10131):1706-1717.
[3]VestboJ,EdwardsLD,ScanlonPD,et al.Changes in forced expiratory volume in 1 second over time in COPD.[J].N Engl J Med,2011,365(13):1184-1192.
[4]Zhou Y,Zhong NS,Li X,et al.Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease[J].N Engl J Med,2017,377(10):923-935.
[5]Martinez FJ,Han MK,Allinson JP,et al.At the Root:Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease[J].Am J Respir Crit Care Med,2018,197(12):1540-1551.
[6]张荣葆,何权瀛,谭星宇.从高危人群中筛查诊断慢性阻塞性肺疾病的效果评估[J].中华结核和呼吸杂志,2009,32(1):17-20.
[7]孙士芳,邓在春,丁群力,等.肺功能检查早期筛查宁波地区慢性阻塞性肺疾病的临床应用[C]//浙江省医学会健康管理学分会学术年会暨健康管理学学科与学术发展论坛.2015.
[8]张晓雷,王辰.重视慢性阻塞性肺疾病的筛查与管理[J].中华健康管理学杂志,2015(4):250-253.
[9]Zaman M,Mahmood S,Altayeh A.Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation[J].Am J Med Sci,2010,339(5):411.
[10]?olak Y,Afzal S,Nordestgaard B G,et al.Young and middle-aged adults withairflow limitation according to lower limit of normal but not fixed ratio have high morbidity and poor survival:a population-based prospective cohort study.[J].Eur Respir J,2018.
[11]Dilektasli AG,Porszasz J,Casaburi R,et al.A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria[J].Chest,2016,150(5):1080-1090.
[12]Mirsadraee M,Boskabady MH,Attaran D.Diagnosis of chronic obstructive pulmonary disease earlier than current Global Initiative for Obstructive Lung Disease guidelines using a feasible spirometry parameter(maximal-mid expiratory flow/forced vital capacity).[J].Chron Respir Dis,2013,10(4):191-196.
[13]Vandevoorde J,Verbanck S,Schuermans D,et al.FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.[J].Chest,2005,127(5):1560-1564.
[14]Hankinson JL,Odencrantz JR,Fedan KB.Spirometric reference values froma sample of the general U.S.population.[J].Am J Respir Crit Care Med,1999,159(1):179-187.
[15]Kjeldgaard P,Lykkegaard J,Spillemose H,et al.Multicenter study of the COPD-6 screening device:feasible for early detection of chronic obstructive pulmonary disease in primary care?[J].Int J Chron Obstruct Pulmon Dis,2017,12:2323.
[16]Thorn J,Tilling B,Lisspers K,et al.Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care:a real-life study and cost-effectiveness analysis[J].Primy Care Respir J,2012,21(2):159.
[17]Bemt LVD,Wouters BCW,Grootens J,et al.Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care:a randomised cross-sectional study[J].NPJ Prim Care Respir Med.,2014,24:14033.
[18]Represas CR,Rial MB,Fernández VL,et al.Validación del dispositivo portátil COPD-6 para la detección de patologías obstructivas de la vía aérea[J].Arch Bronconeumol,2010,46(8):426-432.
[19]Miravitlles M,Llor C,Calvo E,et al.Validación de la versión traducida del Chronic Obstructive Pulmonary Disease-Population Screener,(COPD-PS).Su utilidad y la del FEV1/FEV6,para el diagnóstico de enfermedad pulmonar obstructiva crónica[J].Medicina Clinica,2012,139(12):522-530.
[20]Bateman ED,Hurd SS,Barnes PJ,et al.Global strategy for asthma management and prevention:GINA executive summary[J].Eur Respir J,2008,34(1):143-178.
[21]Chuaychoo B,Maranetra N,Naruman C,et al.The most cost-effective screening method for chronic obstructive pulmonary disease among the Bangkok elderly[J].J Med Assoc Thai,2003,86(12):1140-1148.
[22]Jackson H,Hubbard R.Detecting chronic obstructive pulmonary disease using peak flow rate:cross sectional survey[J].BMJ,2003,327(7416):653-654.
[23]Perez-Padilla R,Vollmer WM,Vázquez-García JC,et al.Can a normal peakexpiratory flow exclude severe chronic obstructive pulmonary disease?[J].Int J Tuberc Lung Dis,2009,13(3):387-393.
[24]田佳,冉丕鑫.成人PEF预计值公式建立及其在COPD患者中的气流受限初筛中作用研究[D].学位论文,广州医学院,2010
[25]刘亚男,许文兵,孟淑珍,等.探究峰流速仪呼气峰流速检测对慢性阻塞性肺疾病的筛查效力[J].中国呼吸与危重监护杂志,2015(3):250-254.
[26]Mahboub B,Alzaabi A,Soriano J B,et al.Case-finding of chronic obstructive pulmonar y disease with questionnaire,peak flow measurements and spirometry:a cross-sectional study[J].BMC Res Notes,2014,7(1):1-7.
[27]Jithoo A,Enright PL,Burney P,et al.Case-finding options for COPD:results from the Burden of Obstructive Lung Disease study[J].Eur Respir J,2013,41(3):548-555.
[28]冉丕鑫,王辰,姚婉贞,等.我国部分农村地区40岁以上女性慢性阻塞性肺疾病危险因素分析[J].中华内科杂志,2006,45(12):974-979.
[29]Pr iceDB,TinkelmanD G,Hal ber tR J,et al.Sy mptom-based questionnaire for identifying COPD in smokers.[J].Respiration,2006,73(3):285-295.
[30]Price DB,Tinkelman DG,Nordyke RJ,et al.Scoring System and Clinical Application of COPD Diagnostic Questionnaires[J].Chest,2006,129(6):1531-1539.
[31]Kawayama T,Minakata Y,Matsunaga K,et al.Validation of symptombased COPD questionnaires in Japanese subjects.[J].Respirology,2008,13(3):420-426.
[32]王娟,许文兵,曾学军,等.中文版慢性阻塞性肺疾病筛查问卷在吸烟者中的初步检验与评价[J].中华内科杂志,2012,51(4):311-312.
[33]石喆,王石林,汪海燕,等.适宜国人BMI分级的慢性阻塞性肺疾病筛查问卷的检验与评价[J].中华全科医师杂志,2014,13(3):184-187.
[34]Dag E,Bulcun E,Turkel Y,et al.Factors Influencing Cognitive Function in Subjects With COPD[J].Respir Care,2016,61(8):1044-1050.
[35]Hung WW,Wisnivesky JP,Siu AL,et al.Cognitive decline among patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2009,180(2):134-137.
[36]Torressánchez I,Rodríguezalzueta E,Cabreramartos I,et al.Cognitive impairment in COPD:a systematic review.[J].J Bras Pneumol,2015,41(2):182-190.
[37]Lópeztorres I,Valenza M C,Torressánchez I,et al.Changes in Cognitive Status in COPD Patients Across Clinical Stages[J].COPD,2015,13(3):327-332.
[38]Dalal AA,Demuromercon C,Lewis S,et al.Validation of alternate modes of administration of the lung function questionnaire(LFQ)in subjects with smoking history[J].Int J Chron Obstruct Pulmon Dis,2010,5:425-434.
[39]Hanania NA,Mannino DM,Yawn BP,et al.Predicting risk of airflow obstruction in primary care:Validation of the lung function questionnaire(LFQ)[J].Respir Med,2010,104(8):1160-1170.
[40]Morfeld M,Bullinger M,Nantke J,et al.[The version 2.0 of the SF-36Health Survey:results of a population-representative study].[J].Soz Praventivmed,2005,50(5):292-300.
[41]冉丕鑫,王辰,姚婉贞,等.体重指数与慢性阻塞性肺疾病及生活质量的关系[J].中华结核和呼吸杂志,2007,30(1):18-22.
[42]Harikkhan RI,Fleg JL,Wise RA.Body mass index and the risk of COPD[J].Chest,2002,121(2):370-376.
[43]Franssen FME,O’Donnell DE,Goossens GH,et al.Obesity and the lung:5·Obesity and COPD[J].Thorax,2008,63(12):1110-1117.
[44]Ora J,Laveneziana P,Ofir D,et al.Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance[J].Am J Respir Crit Care Med,2009,180(10):964-971.
[45]van den Bemt L,Smeele IJ,Kolkman M,et al.Low body mass index,airflow obstruction,and dyspnoea in a primary care COPD patient population[J].Prim Care Respir J,2010,19(2):118-123.
[46]Liu Y,Pleasants RA,Croft JB,et al.Body mass index,respiratory conditions,asthma,and chronic obstructive pulmonary disease[J].Respir Med,2015,109(7):851-859.
[47]Eisner MD,Blanc PD,Sidney S,et al.Body composition and functional limitation in COPD[J].Respir Res,2007,8(1):7.
[48]Steuten LMG,Creutzberg EC,Vrijhoef HJM,et al.COPD as a multicomponent disease:Inventory of dyspnoea,underweight,obesity and fat free mass depletion in primary care[J].Prim Care Respir J,2006,15(2):84-91.
[49]Zhou Y M,Chen SY,Tian J,et al.Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China[J].Int J Tuberc Lung Dis,2013,17(12):1645-51.
[50]Landis S H,Muellerova H,Mannino DM,et al.Continuing to Confront COPDInternational Patient Survey:methods,COPDprevalence,and disease burden in 2012-2013[J].Int J Chron Obstruct Pulmon Dis,2014,9:597-611.
[51]Foreman MG,Zhang L,Murphy J,et al.Early-onset chronic obstructive pulmonary disease is associated with female sex,maternal factors,and African American race in the COPDGene Study[J].Am J Respir Crit Care Med,2011,184(4):414-20.
[52]Varela MVL,Oca MMD,Halbert RJ,et al.Sex-related differences in COPD in five Latin American cities:the PLATINO study[J].Eur Respir J,2010,36(5):1034-1041.
[53]Wang H,Zhang S.Tumor classification based on orthogonal linear discriminant analysis[J].Biomed Mater Eng,2014,24(1):1399-405.
[54]Jun Hwa L,Kyung-Hee K,Ji-Won P,et al.Low-mass-ion discriminant equation:a new concept for colorectal cancer screening[J].Int JCancer,2014,134(8):1844.
[55]Cui J,Zhou Y,Tian J,et al.A discriminant function model as an alternative method to spirometry for COPD screening in primary care settings in China[J].J Thorac Dis,2012,4(6):594-600.
[56]Couillard A,Tremey E,Prefaut C,et al.The self-perception of dyspnoea threshold during the 6-min walk test:a good alternative to estimate the ventilatory threshold in chronic obstructive pulmonary disease[J].Int J Rehabil Res,2016,39(4):320-325.
[57]Chandra D,Wise RA,Kulkarni HS,et al.Optimizing the 6-min walk test as a measure of exercise capacity in COPD[J].Chest,2012,142(6):1545-1552.
[58]邵向荣.6 min步行试验对于慢性阻塞性肺疾病患者的早期筛查意义[J].实用临床医药杂志,2011,15(24):66-67.
[59]Holland AE,Spruit MA,Troosters T,et al.An official European Respiratory Society/American Thoracic Society technical standard:field walking tests in chronic respiratory disease[J].Eur Respir J,2014,44(6):1428-1446.
[60]张雯,孙兴国,彭立悦,等.不同表型的慢性阻塞性肺疾病患者运动能力的比较[J].中国实用内科杂志,2013,33(s1):51
[61]陈燕,熊英,李玲,等.慢性阻塞性肺疾病模型大鼠细胞因子水平变化的研究[J].中华疾病控制杂志,2015,19(8):839-842.
[62]凌燕君.COPD患者诱导痰Th17相关细胞因子与BODE指数和GOLD分级的相关性[J].中华全科医学,2017(5):802-804.
[63]高鹏.基于诱导痰炎症细胞分类的AECOPD新分型及其临床意义的研究[D].吉林大学,2013.
[64]李增艳,卜小宁,苗苗,等.稳定期慢性阻塞性肺疾病患者的去脂质量指数与骨强度的关系[J].中华结核和呼吸杂志,2015,38(1):50-54.
[65]袁俊亮,胡文立.慢性阻塞性肺疾病与认知功能障碍[J].国际呼吸杂志,2013,33(23):1814-1816.
[66]刘音,杨小东.机械通气慢性阻塞性肺病患者腹泻危险因素及致病菌分析[J].临床军医杂志,2018,46(8):928-931.
[67]Welte T,Vogelmeier C,Papi A.COPD:early diagnosis and treatment to slow disease progression.[J].Int J Clin Pract,2015,69(5):513-514.